Mother's milk microbiota is associated with the developing gut microbial consortia in very-low-birth-weight infants.
antibiotics
direct breastfeeding
donor milk
human milk
microbiome
microbiota
mother’s milk
nutrient fortification
preterm infant
very-low-birth-weight infant
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
31 Aug 2024
31 Aug 2024
Historique:
received:
16
04
2024
revised:
30
06
2024
accepted:
16
08
2024
medline:
8
9
2024
pubmed:
8
9
2024
entrez:
7
9
2024
Statut:
aheadofprint
Résumé
Mother's milk contains diverse bacterial communities, although their impact on microbial colonization in very-low-birth-weight (VLBW, <1,500 g) infants remains unknown. Here, we examine relationships between the microbiota in preterm mother's milk and the VLBW infant gut across initial hospitalization (n = 94 mother-infant dyads, 422 milk-stool pairs). Shared zero-radius operational taxonomic units (zOTUs) between milk-stool pairs account for ∼30%-40% of zOTUs in the VLBW infant's gut. We show dose-response relationships between intakes of several genera from milk and their concentrations in the infant's gut. These relationships and those related to microbial sharing change temporally and are modified by in-hospital feeding practices (especially direct breastfeeding) and maternal-infant antibiotic use. Correlations also exist between milk and stool microbial consortia, suggesting that multiple milk microbes may influence overall gut communities together. These results highlight that the mother's milk microbiota may shape the gut colonization of VLBW infants by delivering specific bacteria and through intricate microbial interactions.
Identifiants
pubmed: 39243753
pii: S2666-3791(24)00456-7
doi: 10.1016/j.xcrm.2024.101729
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
101729Informations de copyright
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests E.M.C. acknowledges research support from Lallemand Health Solutions and Ocean Spray and consultant fees, speaker, and/or travel support from Danone, Nestlé, and Lallemand Health Solutions. P.M.S. is a stockholder and an advisory board member for Antibe Therapeutics Inc. A.S. is a co-founder of MedBiome, a clinical microbiomics company.